Jacobs Levy Equity Management
TTOO

Jacobs Levy Equity Management’s T2 Biosystems, Inc TTOO Stock Holding History

Jacobs Levy Equity Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17
Closed -$353K – 1080
2017
Q4 		$353K Buy
+17
New +$351K 0.01% 821

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Jacobs Levy Equity Management's TTOO Position: Q1 2018 in Review

Jacobs Levy Equity Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2018, closing a stake of 17 shares — an estimated $353K sold.

Jacobs Levy Equity Management first reported a position in TTOO in Q4 2017 and held it in 1 quarter. The position peaked at $353K in Q4 2017. 45 funds tracked by Wall St. Rank hold TTOO as of Q1 2018.

  • Jacobs Levy Equity Management reported no remaining T2 Biosystems, Inc position as of Q1 2018 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 17 T2 Biosystems, Inc shares in Q1 2018, an estimated $353K.
  • Jacobs Levy Equity Management first reported a position in T2 Biosystems, Inc in Q4 2017 and held it in 1 quarter.
  • Jacobs Levy Equity Management's T2 Biosystems, Inc position peaked at $353K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2018.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2018, filed 15 May 2018.